Literature DB >> 20852425

Varicocele repair for treatment of androgen deficiency.

Cigdem Tanrikut1, Marc Goldstein.   

Abstract

PURPOSE OF REVIEW: The association between varicocele and male infertility is well established. Modern artery and lymphatic-sparing techniques of varicocele repair have been shown to significantly enhance semen quality and increase pregnancy rates. However, the effect of varicocele on testosterone production is less well defined and the possible association with androgen deficiency is controversial. Data regarding the effects of varicocelectomy on serum testosterone levels are limited and conflicting. RECENT
FINDINGS: Few studies in the past 18 months have assessed the impact of varicocele repair on serum testosterone levels. The limited data available are culled from a diverse patient population with the goal of evaluating other primary outcome parameters and thus provide a challenge for drawing definitive conclusions. One of the more interesting recent studies uses a rat model of varicocele and varicocelectomy to assess changes in intratesticular testosterone levels.
SUMMARY: Although the impact of varicocele on testosterone production is not well understood and the utility of varicocelectomy to prevent or reduce deterioration in Leydig cell function remains unproven, recent data suggest an adverse effect of varicocele and possible benefit of repair. Further human clinical studies are warranted to better define these relationships.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852425     DOI: 10.1097/MOU.0b013e32833f1b5e

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  1 in total

1.  A preliminary evaluation of serum level of testosterone, LH, and FSH in patients with varicocele after varicocelectomy as a kidney-related disease.

Authors:  Mansour Alizadeh; Ali Nasebakht; Rohollah Valizadeh; Mohammadreza Mohammadi Fallah; Ali Taghizadeh Afshari; Mohsen Mohammad Rahimi; Chimen Daneshyar
Journal:  Ther Clin Risk Manag       Date:  2018-09-04       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.